GSA CAPITAL PARTNERS LLP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$586
-12.3%
195,415
-28.0%
0.05%
-25.4%
Q2 2023$668
+373.8%
271,524
+333.8%
0.07%
+378.6%
Q1 2023$141
-67.1%
62,598
-48.9%
0.01%
-73.6%
Q4 2022$428
-99.9%
122,590
+603.4%
0.05%
+8.2%
Q4 2021$393,00017,4290.05%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders